Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Accumulated Expenses: 2024

Historic Accumulated Expenses for Zhengye Biotechnology Holding (ZYBT) over the last 1 years, with Dec 2024 value amounting to $352,000.

  • Zhengye Biotechnology Holding's Accumulated Expenses was N/A to $523,978 in Q2 2025 from the same period last year, while for Jun 2025 it was $523,978, marking a year-over-year change of. This contributed to the annual value of $352,000 for FY2024, which is N/A change from last year.
  • As of FY2024, Zhengye Biotechnology Holding's Accumulated Expenses stood at $352,000.
  • Zhengye Biotechnology Holding's Accumulated Expenses' 5-year high stood at $352,000 during FY2024, with a 5-year trough of $352,000 in FY2024.
  • For the 1-year period, Zhengye Biotechnology Holding's Accumulated Expenses averaged around $352,000, with its median value being $352,000 (2024).